Collegium Pharmaceutical (COLL) Short-term Investments (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Short-term Investments of $19.8 million for Q1 2026, down 80.46% year-over-year from $101.6 million in Q1 2025, and little changed quarter-over-quarter from $19.8 million in Q4 2025.
Collegium Pharmaceutical (COLL) Short-term Investments (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Short-term Investments history runs 5 years deep, the most recent figure standing at $19.8 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 80.46% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (down 80.46% YoY), while the FY2025 annual figure was $19.8 million, down 78.47% from the prior year.
- Short-term Investments for Q1 2026 stood at $19.8 million, roughly flat from $19.8 million in the prior quarter.
- The five-year high for Short-term Investments was $135.8 million in Q3 2025, with the low at $19.8 million in Q2 2025.
- The 4-year median for Short-term Investments is $76.3 million (2023), against an average of $68.1 million.
- The sharpest annual moves came in 2024 and 2026: Short-term Investments soared 136.66% in 2024, then slumped 80.46% in 2026.
- Collegium Pharmaceutical's Short-term Investments stood at $71.6 million in 2023, then gained by 28.77% to $92.2 million in 2024, then slumped by 78.47% to $19.8 million in 2025, then changed by 0.0% to $19.8 million in 2026.
- Business Quant data shows COLL's Short-term Investments at $19.8 million in Q1 2026, $19.8 million in Q4 2025, and $135.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.85 Mn |
| Mar 31, 2026 | 19.85 Mn |
| Dec 31, 2025 | 19.85 Mn |
| Sep 30, 2025 | 135.77 Mn |
| Jun 30, 2025 | 19.85 Mn |
| Mar 31, 2025 | 101.58 Mn |
| Dec 31, 2024 | 92.20 Mn |
| Sep 30, 2024 | 81.00 Mn |
| Jun 30, 2024 | 98.74 Mn |
| Mar 31, 2024 | 89.44 Mn |
| Dec 31, 2023 | 71.60 Mn |
| Sep 30, 2023 | 46.03 Mn |
| Jun 30, 2023 | 41.72 Mn |
| Dec 31, 2014 | 2.34 Mn |